Real-time intravascular photoacoustic-ultrasound imaging of lipid-laden plaque in human coronary artery at 16 frames per second by Hui, Jie et al.
1Scientific RepoRts | 7: 1417  | DOI:10.1038/s41598-017-01649-9
www.nature.com/scientificreports
Real-time intravascular 
photoacoustic-ultrasound imaging 
of lipid-laden plaque in human 
coronary artery at 16 frames per 
second
Jie Hui  1, Yingchun Cao2, Yi Zhang1, Ayeeshik Kole2,3, Pu Wang  2, Guangli Yu4, Gregory 
Eakins5, Michael Sturek2,3, Weibiao Chen4,6 & Ji-Xin Cheng2,7,8
Intravascular photoacoustic-ultrasound (IVPA-US) imaging is an emerging hybrid modality for the 
detection of lipid-laden plaques, as it provides simultaneous morphological and lipid-specific chemical 
information of an artery wall. Real-time imaging and display at video-rate speed are critical for clinical 
utility of the IVPA-US imaging technology. Here, we demonstrate a portable IVPA-US system capable 
of imaging at up to 25 frames per second in real-time display mode. This unprecedented imaging 
speed was achieved by concurrent innovations in excitation laser source, rotary joint assembly, 1 mm 
IVPA-US catheter size, differentiated A-line strategy, and real-time image processing and display 
algorithms. Spatial resolution, chemical specificity, and capability for imaging highly dynamic objects 
were evaluated by phantoms to characterize system performance. An imaging speed of 16 frames per 
second was determined to be adequate to suppress motion artifacts from cardiac pulsation for in vivo 
applications. The translational capability of this system for the detection of lipid-laden plaques was 
validated by ex vivo imaging of an atherosclerotic human coronary artery at 16 frames per second, 
which showed strong correlation to gold-standard histopathology. Thus, this high-speed IVPA-US 
imaging system presents significant advances in the translational intravascular and other endoscopic 
applications.
Coronary artery disease remains the leading cause of morbidity and mortality throughout the world. 
Atherosclerosis, a major form of coronary artery disease, occurs in many different forms and can be distin-
guished by morphologic classification into different plaque types1. Among them, the thin-capped fibroatheroma 
has been understood to be the most “vulnerable” plaque type, as evidence shows it is the most prone to rupture 
and progress to thrombosis and acute coronary syndrome1–4. Thin-capped fibroatheromas are grossly defined 
by hallmarks of a large lipid-rich necrotic core, a thin fibrous cap, and inflammatory infiltrate2, 4. In addition, 
these plaques are often structurally non-obstructive to moderately obstructive, thus clinically unidentifiable by 
routine angiography and stress testing2, 5, 6. Currently, there are no clinically available imaging tools to reliably 
and accurately detect vulnerable plaques7–9. Angiographic techniques, including X-ray angiography, computed 
tomography angiography, and magnetic resonance angiography, are limited to visualizing areas of severe luminal 
narrowing. Intravascular ultrasound (IVUS) provides the overall morphology of artery wall for quantification 
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of the plaque burden and monitoring disease progression, but lacks chemical selectivity to identify plaque com-
position. Virtual-histology IVUS, based on radiofrequency (RF) analysis of the ultrasound signal, provides val-
uable information of the plaque composition10, 11, but still has not been thoroughly validated12, 13. Intravascular 
near-infrared spectroscopy (NIRS) has been shown to reliably detect lipid-rich plaques in the artery wall14, 15, but 
lacks imperative depth resolution to quantify the size and location of the lipid deposition. Intravascular optical 
coherence tomography can accurately detect fibrous cap thickness with micron-scale resolution16, but lacks suf-
ficient imaging depth and chemical selectivity to wholly determine plaque composition. These gaps, along with 
the increasing prevalence of coronary artery disease, highlight an unmet clinical need for a chemically-selective 
imaging modality with spatial resolution to advance the detection, understanding, and treatment of lipid-laden 
vulnerable plaques.
Dual-mode intravascular photoacoustic-ultrasound (IVPA-US) imaging is a promising approach to bridge the 
aforementioned gaps. In this hybrid modality, IVPA channel maps the lipid-specific chemical composition over 
the entire artery wall with ultrasonic spatial resolution. Based on conversion of optical absorption into ultrasound 
signal, photoacoustic (PA) imaging provides chemical selectivity and deep penetration depth17–20. Specifically, 
the lipid-specific contrast is generated endogenously from the first overtone absorption of C-H bonds at 1.7 µm 
wavelength21, 22 and the PA signal is one order of magnitude greater than that of water and connective tissues22. 
Furthermore, IVPA imaging works concurrently with IVUS imaging, which can provide simultaneous morpho-
logical information. Therefore, a co-registered IVPA-US image provides complementary information necessary 
for advanced and quantitative assessment of lipid-laden vulnerable plaques.
The IVPA-US imaging technology is currently under active investigation for the identification of various tissue 
components21, 23, 24, contrast mechanism21, 22, optical excitation sources25–27, IVPA-US catheter designs27–31, and ex 
vivo and preclinical validations32–34. However, these works are limited by the use of slow imaging speeds (up to 5 
frames per second (fps)27) as well as lack of real-time image display, which are necessary components for future 
in vivo applications where imaging must be at a sufficient speed to avoid motion artifacts from cardiac pulsation. 
Motion artifacts can lead to inaccurate spatial mapping and quantification of lipid deposition, and subsequent 
misinterpretation of plaque type. Furthermore, a lack of real-time processing and display capability would pre-
vent user feedback necessary to adjust imaging parameters and location.
In this work, we overcame these limitations by presenting a portable IVPA-US system capable of imaging in 
real-time, up to 25 fps. In this system, a master oscillator power amplifier (MOPA)-pumped optical parametric 
oscillator (OPO) with a wavelength of 1.7 µm and a repetition rate of 2 kHz was used as the optical excitation 
source. A compact fiber-optic rotary joint provided efficient and stable optical coupling with a scanning speed up 
to 30 revolutions per second. A 1 mm diameter collinear IVPA-US catheter was built for high-sensitivity imaging. 
A differentiated A-line strategy, where the triggering frequency for US was doubled to that of PA, was applied 
to maximize IVPA-US imaging functionality. Lastly, LabView-based algorithms were developed to process and 
display IVPA-US images in real-time. These developments enabled the 25 fps imaging speed, a 5 times improve-
ment over any previously reported IVPA-US imaging speed and comparable to the imaging speeds of current 
commercial IVUS and NIRS-IVUS systems35.
Results
High-speed real-time IVPA-US imaging system. We designed and developed the compact and porta-
ble IVPA-US imaging system as shown in Fig. 1(a). The detailed connections and controls of these components 
were shown in Fig. 1(b). Briefly, in the system, a 1.7 µm, 2 kHz MOPA-pumped OPO was used for high-speed 
optical excitation. Its output pulses were coupled to a multimode fiber through a coupling mount, then a fib-
er-optic rotary joint, and lastly the IVPA-US catheter tip. Initial ultrasound pulses generated from an ultrasound 
pulser were sent to the catheter tip through a slip ring. The delays between the ultrasound and optical pulses 
were precisely controlled by a delay generator. The B-scan and linear pullback of the catheter was conducted with 
the fiber-optic rotary joint assembly and rotation and pullback rate controlled by a computer. The sequentially 
generated PA and US signals were detected by the IVPA-US catheter, transmitted by the slip ring, amplified by 
Figure 1. High-speed real-time IVPA-US imaging system. (a) Image of the portable IVPA-US imaging system. 
Major components: 1, oscilloscope; 2, fiber-optic rotary joint assembly; 3, IVPA-US catheter; 4, delay generator; 
5, ultrasound pulser/receiver; 6, MOPA-pumped OPO; 7, laser controller; 8, mobile cart; 9, laser chiller; 10, PC 
and DAQ card; 11, image display monitor. (b) Schematic of IVPA-US imaging system layout. Dashed black line: 
trigger signal; solid black line: stage control cable; solid green line: radiofrequency signal.
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the ultrasound receiver, digitized and recorded by a data acquisition (DAQ) card, and further processed and dis-
played in real-time. This IVPA-US system was capable of imaging in real-time at speed up to 25 fps. The imaging 
speed was achieved by innovations in several key components, which are presented as below.
The determining factor for imaging speed is the laser pulse repetition rate, as each laser pulse corresponds to 
a depth-resolved A-line signal. In this system, a custom-built MOPA-pumped OPO was used for 2 kHz optical 
excitation, with the optical layout detailed in Fig. 2(a). The master oscillator provided 2.5 mJ and 15 ns laser pulses 
at 1064 nm with a 2 kHz repetition rate. The output was amplified to 6.0 mJ by a laser diode side-pumped optical 
power amplifier. Its wavelength was further shifted to 1.7 µm by a potassium titanyl phosphate (KTP)-based OPO. 
The performance of the laser output was further characterized. The final output wavelength was measured to be 
1725 nm, which coincides with the first overtone transition frequency of C-H bonds (Fig. 2(b)). Thus, laser pulses 
at this wavelength were effectively absorbed by C-H bond-rich lipids, which generated strong PA signals. The 
output power was tunable in a range of 2.1 W, sufficient for lipid excitation (Fig. 2(c)). Other laser performance 
characterizations were shown in Supplementary Fig. S1. Collectively, this laser source was optimal for high-speed 
IVPA imaging of lipids.
The catheter used in the system had a collinear IVPA-US design with a diameter of 1 mm. Fig. 3(a) showed the 
actual image of a fully assembled collinear IVPA-US catheter, with the detailed schematic of the catheter imaging 
window shown in Fig. 3(b). In this design (further details found elsewhere28), the incident optical wave and its 
generated ultrasound wave were collinearly aligned, providing efficient overlap between the optical and acoustic 
paths over an imaging depth of >6 mm. In this work, we further miniaturized the catheter diameter to 1 mm, a 
clinically-compatible size adopted by most commercial IVUS systems. The reduction in diameter was achieved 
by aligning a miniaturized single element transducer (0.5 × 0.6 × 0.2 mm3), a multimode fiber with core diameter 
of 365 µm, and a reflection rod mirror with diameter of 365 µm in a 3-D printed housing. The beam path and 
beam characteristics were shown in Supplementary Fig. S2. The inset in Fig. 3(b) showed the actual image of an 
assembled IVPA-US catheter tip. This catheter provided high-sensitivity IVPA-US imaging capability and its size 
made access into human coronary artery samples feasible.
The fiber-optic rotary joint assembly is another key element that enabled the high-speed imaging. The assem-
bly simultaneously provided optical coupling, RF signal transmission, fast rotary scan, and linear pullback. The 
compact and portable assembly was shown in Fig. 3(c). The rotary motor and the linear stage were used to pro-
vide rotary scan and linear pullback of catheter for 3-D imaging. The fiber-optic rotary joint was used to provide 
sufficient and stable optical coupling at high rotational speeds. The design of fiber-optic rotary joint was shown 
in Fig. 3(d). In this design, the use of two adjacent collimators and a mating sleeve enabled an overall coupling 
efficiency of 60% from the initial optical input to the final output at the catheter tip. Furthermore, the design sig-
nificantly minimized the coupling efficiency variation usually caused by the mechanical rotation to 5.4%. Thus, 
the artery wall was uniformly excited in laser pulse energy at every angular position. The fiber-optic rotary joint 
was further driven by the motor with rotational speed up to 30 revolutions per second.
To maximize IVPA-US imaging functionality at high imaging speeds, a differentiated A-line strategy was 
designed. Fig. 4(a) showed the timing diagram for the A-line strategy. The transistor-transistor logic (TTL) sig-
nal from the laser was used to trigger DAQ card. The same trigger was delayed and frequency-doubled through 
Figure 2. 1.7 µm 2 kHz MOPA-pumped OPO for high-speed optical excitation. (a) Schematic of MOPA-
pumped OPO. Dashed boxes labeled by I, II, and III highlight the master oscillator, optical power amplifier, 
and OPO, respectively. LD, laser diode; CL, coupling lens; M1 and M5, fold mirror; M2, M10, and M11, flat 
mirror; M3, M4, M6, M7, M8, M12, and M13, reflective mirror; M9, dichroic mirror; P, polarizer; BBO, beta 
barium borate Pockels cell; OC, output coupler; L, lens; KTP, potassium titanyl phosphate; W, output window. 
(b) Output wavelength of the laser (black curve), 1725 nm, matching the maximum peak in photoacoustic 
spectrum of lipids (blue curve). (c) Output power with control current. Other performance parameters can be 
found in Supplementary Fig. S1.
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multiplexing by a delay generator to trigger initial ultrasound pulses. As a result, the digitized signal in one 
acquisition cycle contained one PA signal segment and two US signal segments. Thus, the number of A-lines in 
a cross-sectional IVUS image was two times of that in IVPA image. Specifically, at 16 fps, 125 A-lines were used 
to reconstruct a cross-sectional IVPA image; 250 A-lines were used to reconstruct a cross-sectional IVUS image, 
comparable to current commercial systems. In order to verify the use of 125 A-lines in IVPA image, we charac-
terized IVPA lateral resolution by imaging of a single 30 µm diameter carbon fiber submerged in heavy water. The 
cross-sectional IVPA image at 16 fps was shown in Fig. 4(b) and its lateral resolution of 305 µm was estimated by 
the full-width-at-half-maximum (FWHM) of the Gaussian fitted curve of the raw data points in the lateral direc-
tion at an axial position of 2.38 mm (Fig. 4(c)). At this axial position, there were 2.5 A-lines sampled in the lateral 
resolution of 305 µm, which indicates that signals in IVPA image were adequately sampled in the lateral direction 
based on the Nyquist sampling theorem (2.5 was calculated by L/(2 * pi * R/N), where L is the lateral resolution, 
N is the number of A-lines per cross-sectional image, and R is the axial position). Using the same methodology, 
there were constantly ~2.5 A-lines sampled in the lateral resolution at every axial position for 16 fps IVPA imaging 
(calculated based on the data in Fig. 4(d)). Thus, the use of 125 A-lines should provide adequate image quality for 
IVPA imaging. Meanwhile, we characterized the lateral resolutions at different axial positions at other imaging 
speeds (Fig. 4(d)). Notably, when the axial position was increased, the lateral resolution decreased, varying from 
150 to 600 µm. However, there was no significant difference in lateral resolution at each axial position at different 
imaging speeds.
To achieve real-time display of IVPA-US images, we developed fast processing and display algorithms. The 
processing flow was shown in Supplementary Fig. S3 and the details were in Methods. Briefly, the digitized data 
containing non-meaningful signals was discarded in a preprocessing loop. The remaining PA and US segments 
were processed, reconstructed, and displayed in parallel IVPA and IVUS loops. A polar projection module was 
applied to convert IVPA and IVUS signals into polar images simultaneously. Through this program, we were able 
to image and display in real-time. (More details about the high-speed real-time IVPA-US imaging system can be 
found in Methods).
IVPA-US imaging of pulsatile motion at different speeds. To find the optimal speed to image arter-
ies with cardiac motion in in vivo settings, a phantom with pulsatile motion mimicking a human heartbeat was 
imaged at different speeds: 1, 5, 10, 16, 20, and 25 fps. Heat shrink tubes have a high absorption and can gen-
erate strong PA signal in a broad optical spectrum including 1.7 µm. Thus, we used a short heat shrink tube 
segment with a ~6 mm diameter in a heavy water environment as the phantom. At the time of imaging, the 
pulsatile motion was generated by mechanically pinching the tube at 1.2 Hz with forceps. The demonstration of 
real-time IVPA-US imaging of heat shrink tube at 16 fps and 25 fps can be found in Supplementary Video S1 and 
Supplementary Video S2, respectively. Supplementary Video S3 showed the merged IVPA-US images at speeds 
Figure 3. 1-mm high-sensitivity catheter and fiber-optic rotary joint assembly for high-speed IVPA-US 
imaging. (a) Gross picture of flexible IVPA-US catheter with a 1 cent coin. Proximal end of the catheter was 
assembled with a FC/PC connector. (b) Schematic of 1-mm collinear IVPA-US catheter design. The red ellipses 
and black curves highlight the collinear paths of optical pulses and acoustic waves, respectively. Inset shows 
the actual picture of assembled catheter tip. Ruler scale: 1 mm. (c) Picture of overall fiber-optics rotary joint 
assembly. (d) Schematic of fiber-optic rotary joint for high-pulse-energy high-repetition-rate laser delivery.
www.nature.com/scientificreports/
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of 1, 5, 10, 16, 20, and 25 fps, respectively. In this video, IVPA and IVUS signals from the circumference of the 
phantom were detected at all imaging speeds. The imaging speed did not affect detection sensitivity and IVPA-US 
co-registration. However, IVPA-US imaging at speeds of 1 and 5 fps was not able to accurately capture 1.2 Hz pul-
satile motion. The speed of 10 fps was acceptable, but its slow refresh rate was noticeable. However, there was no 
observable difference among the speeds of 16, 20, 25 fps in capturing the 1.2 Hz pulsatile motion. Thus, IVPA-US 
images at low imaging speeds were subject to distortion from motion artifacts. As contrasting examples, four 
consecutive IVPA-US images at 1 fps (Fig. 5(a)), 5 fps (Fig. 5(b)), 10 fps (Fig. 5(c)), and 16 fps (Fig. 5(d)) were used 
to demonstrate the distortion. At lower imaging speeds, there was obvious A-line signal mismatch at 6 o’clock, 
where the first and final A-lines in a cross-sectional image were located (e.g. Frames #2 and #4 in Fig. 5(a), Frames 
#2 and #3 in Fig. 5(b), Frame #4 in Fig. 5(c)). However, at 16 fps, the mismatch became negligible (Fig. 5(d)). 
Furthermore, the overall shape of shrink tube at lower speeds was distorted, especially for images at speeds of 
1 and 5 fps (e.g. Frames #1—4 in Fig. 5(a), Frames #2 and #3 in Fig. 5(b)); while the distortion was successfully 
suppressed at 16 fps and its images reflected the real tube cross-sections (Fig. 5(d)). Lastly, at 16 fps, the dynamic 
change on tube shape from Frame #1 to #4 in Fig. 5(d) was continuous; but, at 1 fps, such continuity was not 
shown (Fig. 5(a)). Thus, a 16 fps imaging speed should be sufficient to avoid motion artifacts induced by cardiac 
pulsation for in vivo IVPA-US imaging.
IVPA-US imaging of tissue phantom at 16 fps. To test the chemical specificity of our imaging sys-
tem, we imaged different tissue components, including intramuscular fat, tendon, and muscle tissue, at 16 fps. 
Intramuscular fat is rich in CH2 groups and has similar optical absorption at 1.7 µm as intravascular lipids, thus 
was used to mimic a lipid-laden plaque. Tendons and muscle tissue were used to mimic the medial layer of an 
artery, which is composed of vascular smooth muscle cells and collagen-rich extracellular matrix. These tissue 
components were harvested from a swine and dissected into small segments to be embedded into 2.5% agar gel as 
shown in Fig. 6(a). A central lumen was created in the phantom to insert the imaging catheter and the phantom 
was submerged in heavy water during the experiment. A 10 mm pullback of the phantom was captured at 16 fps 
with a pulse energy of 60 µJ (30.69 mJ/cm2 for laser fluence, calculation found in Supplementary Fig. S2) on the 
Figure 4. Differentiated A-line strategy and A-line number verification for IVPA-US imaging at 16 fps.  
(a) Timing diagram of IVPA-US imaging. τ0, 0 µs; τ1, 0.126 µs; τ2, 8.126 µs; τ3, 258.126 µs. TTL trigger refers to the 
trigger signal from laser. (b) Cross-sectional IVPA image of a single carbon fiber with diameter of 30 µm for 
spatial resolution characterization. The image shown was reconstructed by raw imaging data without A-line 
interpolation. Inset shows the zoom-in IVPA image. Scale bar: 1 mm. (c) Lateral plot of the carbon fiber in IVPA 
image at an axial position of 2.38 mm. The lateral resolution of 305 µm is estimated by the full with at half 
maximum (FWHM) of Gaussian fitted curve. (d) IVPA lateral resolution at different axial position at imaging 
speeds of 1, 5, 10, and 16 fps.
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sample and a pullback speed of 0.5 mm/s. In the pullback, 320 frames of IVPA and IVUS data were acquired 
and reconstructed. Supplementary Video S4 showed the entire pullback. Fig. 6(b–d) showed the IVPA, IVUS, 
and merged images at one selected position, respectively. The image frames were 3-D rendered along the pull-
back direction (3-D rendering method was shown in Fig. 6(e)), showing the overall spatial distribution of each 
imaged tissue component (Fig. 6(f–h) and Supplementary Video S5). In the IVPA channel, only intramuscular 
fat generated signal, with a signal-to-noise ratio of 46.8 (Fig. 6(f)). However, in the IVUS channel, all three tissue 
components generated similar levels of signal. Thus, these results validated the chemical selectivity of our imaging 
system, indicating that lipid deposition in an artery can be specifically mapped.
IVPA-US imaging of human coronary atherosclerosis and comparison to histopathology. To 
further validate the imaging system for the detection of lipid-laden plaques, a diseased human coronary artery 
was imaged ex vivo. The right coronary artery was dissected from a human heart, collected from a 44-year old 
male who died of atherosclerotic hypertensive cardiovascular disease (gross image was shown in Fig. 7(a)). The 
artery sample was pressure-fixed in 10% w/v formalin and immobilized in a Sylgard tray with metal pins and 
submerged in heavy water as shown in Fig. 7(b). A protective polyimide sheath was used to enclose the IVPA-US 
catheter except for the imaging window at the catheter tip. The catheter and sheath were inserted to the artery 
lumen for IVPA-US imaging at 16 fps and with a pulse energy of 80 µJ (40.93 mJ/cm2 for laser fluence) on the 
Figure 5. IVPA-US imaging of pulsatile motion at different speeds. Four consecutive IVPA-US frames selected 
at speed of (a) 1 fps, (b) 5 fps, (c) 10 fps, and (d) 16 fps highlighting the imaging distortion induced by pulsatile 
motion at lower imaging speed, while demonstrating the capability to suppress the motion artifacts at 16 fps. 
Complete comparison of IVPA-US imaging results at different imaging speed (1, 5, 10, 16, 20, and 25 fps) can be 
found in Supplementary Video S3. The depth field of view is 5.09 mm. Scale bar: 1 mm.
www.nature.com/scientificreports/
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sample, which is below the 1.0 J/cm2 ANSI safety standard for skin exposed in 1.7 µm laser36. A positive region of 
interest was identified based on IVPA, IVUS, and merged images in Fig. 7(c–e), which was further marked with a 
metal pin as shown in Fig. 7(b). There were two sites of lipid deposition at the 2 and 8 o’clock positions, as recog-
nized by strong signals in the IVPA channel (Fig. 7(c)). There was a noticeable lipid-rich core at the 2 o’clock posi-
tion, which correlated with luminal encroachment observed in the IVUS channel (Fig. 6(d)). The co-registered 
IVPA-US image (Fig. 7(e)) suggested that this lipid-rich core was beneath a fibrous cap of the plaque surface 
shown by signal in the IVUS channel. To validate our imaging results, we performed gold-standard histopathol-
ogy at the region of interest. Fig. 7(f) provided an overall image of histology. The lumen and artery structure in 
the histological section correlated with artery morphology as shown in the IVUS channel. Furthermore, the areas 
between 5 and 9 o’clock was rich in fibrous tissue, correlating with the strong echogenicity observed in the IVUS 
channel at the same location. Also apparent were two lipid-rich necrotic cores (Fig. 7(g,h)), as identified by the 
loss of matrix, cholesterol clefts, and macrophage infiltration into the lipid pool with an overlying fibrous cap 
(200 µm thickness). Based on these histological hallmarks, we identified this plaque as an advanced fibroather-
oma, which showed strong correlation with our imaging results.
Discussion
In summary, we have demonstrated a real-time IVPA-US imaging system for the detection of lipid-laden plaque 
in a human coronary artery at 16 fps. In this system, we presented several key innovations, including excitation 
laser source, fiber-optic rotary joint assembly, 1 mm diameter IVPA-US catheter, and real-time image processing 
and display algorithms. By imaging pulsatile motion at different imaging speeds, 16 fps was determined to be 
adequate to suppress motion artifacts from cardiac pulsation for future in vivo applications. Using this system, we 
further imaged and identified a lipid-laden plaque ex vivo in a human coronary artery, which was confirmed by 
gold-standard histopathology. Collectively, this work offered significant advances towards the clinical translation 
of IVPA-US imaging technology.
Imaging speed has been a remaining challenge in development of IVPA/US imaging technology, primarily 
limited by laser pulse repetition rate. In this work, we overcame this obstacle by using a MOPA-pumped OPO 
with a 2 kHz optical excitation and achieved up to 25 fps imaging speed, making the IVPA-US system compa-
rable to the commercial IVUS and NIRS-IVUS systems. Although a video-rate speed at 30 fps is preferred for 
in vivo applications, achieving so would potentially be cost-prohibitive during laser sourcing and development. 
Moreover, our imaging results concluded that 16 fps imaging speed does not suffer from motion artifacts induced 
by cardiac pulsation. Meanwhile, this speed was achieved without significantly compromising image quality with 
the reciprocal reduction of number of A-lines per image frame. To further improve the IVPA imaging quality at 
16 fps, we can use a number of strategies including slightly increasing the laser repetition rate (but number of 
A-lines does not necessarily to be the same as that in IVUS channel) or using less A-lines per image frame paired 
with advanced reconstruction algorithms that exploit speckle differences in PA and US imaging37.
Figure 6. IVPA-US imaging of tissue phantom at 16 fps. (a) Picture of tissue phantom. F, intramuscular fat; T, 
tendon; M, muscle. Cross-sectional (b) IVPA, (c) IVUS, and (d) merged images of the tissue phantom. The scale 
bar and the coordinates in (b) is also applied to (c,d). (e) 3-D rendering method. 3-D rendered (f) IVPA, (g) 
IVUS, and (h) merged images of the tissue phantom with a pullback length of 10 mm. The coordinates in (f) is 
also applied to (g,h). Scale bar: 1 mm.
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Real-time imaging capability is also a critical feature for clinical translation of the IVPA-US technology. It 
can provide operator the necessary and timely feedback to adjust imaging parameters based on their operational 
requirements. These include the laser pulse energy, the amplification of signals, the pullback speeds, and the 
image processing parameters. Moreover, the real-time imaging allows to accurately locate the catheter tip at the 
time of imaging and instantly revisit an identified region of interest. The high-speed real-time imaging capability, 
along with the superior chemical selectivity and high scalability of PA imaging, makes the imaging system ver-
satile for other intravascular and endoscopy applications. By using a different excitation wavelength or multiple 
wavelengths, our system could be used to detect other plaque components, e.g. intraplaque hemorrhage or loss of 
collagen in the fibrous cap. Furthermore, exogenous contrast agents could be employed to target other markers 
of plaque vulnerability such as macrophage infiltration or matrix metalloproteinases38–40. Our system may also 
resolve the current limitations (slow imaging speed, 4 Hz; partial field of view) encountered in PA endoscopy of 
gastrointestinal tracts41.
Our system is currently limited by the lack of an optically and acoustically transparent sheath fully enclosing 
the IVPA-US imaging catheter. A sheath is a necessary component in a clinical setting to protect the catheter 
components and the artery endothelium. In addition, the sheath must be flexible and have a clinically compatible 
Figure 7. IVPA-US imaging of human coronary atherosclerosis at 16 fps with comparison to histopathology. 
(a) Picture of collected human heart. (b) Scenario picture of ex vivo IVPA-US imaging of dissected human 
coronary artery. The region of interest was marked by metal pin. The catheter and sheath were inserted into 
the artery lumen. Cross-sectional (c) IVPA, (d) IVUS, and (e) merged images of human coronary artery at 
the region of interest. (f) Gold-standard histopathology stained with Movat’s pentachrome at the region of 
interest. (g,h) Magnified images of lipid deposition sites corresponding to the dashed boxes in (f). *Indicates the 
accumulation of cholesterol clefts.
www.nature.com/scientificreports/
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size. Lastly, a clinically relevant animal model of atherosclerosis will be critical in refining the catheter and the 
sheath designs and preclinical validation of the technology in vivo.
Methods
MOPA-pumped OPO. The detailed optical layout of the laser was shown in Fig. 2(a). In the MOPA configu-
ration, a Nd:YAG laser side-pumped by a laser diode was used as the master oscillator, generating 2.5 mJ and 15 ns 
laser pulses at a frequency of 2 kHz and a wavelength of 1064 nm. The output of the laser diode was collimated 
onto the Nd:YAG crystal through a pair of coupling lenses. A BBO Pockels cell was used as the electro-optical 
Q-switch along with a polarizer and a quarter-wave plate. A Nd:YAG rod side-pumped by a collimated laser diode 
was applied as the power amplifier. After the amplification, the pulse energy reached 6.0 mJ at a wavelength of 
1064 nm and a pulse duration of 15 ns. The wavelength of the laser pulses was shifted to 1.7 µm as the final output 
by a KTP-based OPO. In the OPO cavity, two KTP crystals were specially cut to realize the type II phase matching 
and placed with opposite orientation to effectively reduce the walk-off effect. The temperature of the laser rods 
and the KTP crystals were kept at 295 K for effective heat dissipation. All optical components were installed and 
enclosed in a compatible aluminum alloy box with dimensions of 107 × 260 × 430 mm3. The performance of the 
laser output was further characterized as shown in Fig. 2(b,c) and Supplementary Fig. S1.
IVPA-US catheter. We designed and assembled a new 1 mm catheter for simultaneous IVPA and IVUS 
imaging. The detailed design was shown in Fig. 3(a,b). In the catheter, a multimode fiber (FG365LEC, Thorlabs) 
was used to guide the optical beam. The proximal end of the fiber was polished to 90° and assembled with a FC/
PC connector for light coupling. The distal end was polished to 47° to realize the collinear overlap between the 
optical and acoustic paths (Supplementary Fig. S2), considering the small difference in refraction index between 
the fiber core (1.44) and water or heavy water (1.33). A single element ultrasound transducer (center frequency, 
40 MHz; bandwidth, 52%; size, 0.5 × 0.6 × 0.2 mm3; Blatek Inc.) was used to receive generated PA and US signals 
sequentially. A 45° rod mirror (made from the same fiber, polished to 45° and coated with gold, with an optical 
reflection of 99% and a damage threshold of 1 J/cm2) was used to reflect both optical and acoustic waves. The 
catheter housing (Proto Labs Inc.) was 3-D printed with micro-resolution stereolithography process to enclose 
and align the relative positions of fiber distal end, rod mirror, and ultrasound transducer. The fabrication was 
completed on a workstation capable of aligning these components precisely and monitoring the PA and US sig-
nals in real-time under aqueous environment.
Data acquisition, image processing and display algorithm. In order to process and display IVPA-US 
images in real-time, we developed LabView-based algorithms and an intuitive graphical user-friendly interface. 
First, we used a differentiated A-line strategy for IVPA and IVUS imaging by doubling the US triggering fre-
quency (Fig. 4(a)). Specifically, the TTL signal from the laser was used to trigger data acquisition. The same signal 
was also used to generate two delayed TTL signals (one channel was delayed for 8 µs and the other for 258 µs) 
through a delay generator (9512+, Quantum Composer). The two channels were further multiplexed for trig-
gering ultrasound pulser/receiver. Thus, the signal recorded in each acquisition cycle contained one PA signal 
segment, two US signal segments, and the remaining non-meaningful signal. The signal was then processed 
by developed image processing and display algorithms (the processing flow shown in Supplementary Fig. S3). 
Finally, the IVPA and IVUS images were displayed separately on screen in real-time. Using the same method-
ology as that in 16 fps imaging, we achieved 10, 20, and 25 fps real-time image processing and display. In 10 fps 
IVPA-US imaging, 200 and 400 raw A-lines were used to reconstruct cross-sectional IVPA and IVUS images, 
respectively. Similarly, for 20 fps, 100 and 200 raw A-lines for IVPA and IVUS images; for 25 fps, 80 and 160 raw 
A-lines for IVPA and IVUS images. For 1 and 5 fps, the US triggering frequency was the same as PA, thus IVPA 
and IVUS images had the same number of A-lines. For 1 fps, IVPA and IVUS images both had 2000 raw A-lines. 
For 5 fps, both images had 400 raw A-lines. For off-line image reconstruction, an additional median filter was 
used to reduce noise in both IVPA and IVUS images. An A-line interpolation method was further implemented 
into the reconstruction algorithm smoothing both IVPA and IVUS images. This was a method that applied inter-
polation for raw data points along the lateral direction, through which the discontinuity between raw A-lines can 
be smoothed.
IVPA-US imaging system. The portable IVPA-US imaging system was shown in Fig. 1(a,b). In the sys-
tem, the laser output was coupled to a multimode fiber (FG365LEC, Thorlabs) through a fiber coupling mount 
(Supplementary Fig. S4). A designed fiber-optic rotary joint (Fig. 3(c,d)) delivered the laser beam to the IVPA-US 
catheter tip sequentially through the following optical parts: SMA collimator (F220SMA-C, Thorlabs) for beam 
collimation, a second SMA collimator (F220SMA-C, Thorlabs) used for coupling the beam into a terminated fiber 
end, a SMA-to-SMA mating sleeve (ADASMA, Thorlabs) used to properly align the cores of the each terminated 
fiber end and minimize back reflection. Each terminated fiber end was assembled with a SMA connector. The sec-
ond collimator, the short fiber segment, and the mating sleeve were fixed in place and enclosed by a metal rotor. 
Three bearings were assembled onto the proximal end of the rotor and then installed into a stator; while the first 
collimator was fixed in place into the other end of the stator. The rotator drove the rotor and the optical compo-
nents in the rotor at a set speed. A step motor (X-NMS17C-E01, Zaber) was used to drive the rotator through a 
belt for cross-sectional scanning; a linear stage (X-LRM100A, Zaber) was integrated for pullback. The speeds of 
rotational scanning and linear pullback were controlled by a computer. The optical pulses and initial ultrasound 
pulses were sequentially sent to the IVPA-US catheter through the multimode fiber and the electric wire of the 
ultrasound transducer, respectively, to generate IVPA and IVUS signals. The detected signal was transmitted 
through a slip ring. Electronic noise induced by the assembly was suppressed by electrical grounding and shield-
ing. The signal was received and amplified (39 dB) by an ultrasound receiver (5073PR, Olympus, Inc.), digitized 
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and acquired by a DAQ card (ATS9350 PCI express digitizer, AlazarTech) with waveform digitization of 12-bit, 
sampling rate of 500 MS/s, and data throughput of 1600 MB/s. The digitized data was processed and displayed in 
real-time by the computer. The laser chiller used was a non-compressor based chiller. This robust, compact, and 
portable design is essential for future work in catheterization labs for preclinical and clinical studies.
Human artery samples and histology. Human specimens were obtained within 24 hours of death from 
deceased patients bequeathed to Indiana University School of Medicine, as approved by Institutional Review 
Board exemption. The studied donor sample was from a 44-year old Caucasian male with a body mass index of 
32.4, past medical history of a previous myocardial infarction, smoking and alcohol use, and hypertension, and 
died from atherosclerotic hypertensive cardiovascular disease. The right coronary artery was excised from sur-
rounding bulk myocardium. Small side branches were ligated with ligation clips to allow for pressure-perfusion 
and the proximal portion of the artery was cannulated using a modified 6 F hemostatic introducer sheath. To 
maintain the vessel morphology, we pressure-fixed the artery using 10% w/v formalin with a large barrel syringe 
(140 mL Monoject, Covidien) for 20 minutes at 225 mL/min, which approximately translated to a physiologic 
pressure. The artery was left in formalin overnight to ensure fixation. We imaged the vessel by first submerging 
and perfusing it with room temperature 1X PBS, pH 7.4 to remove all air. Next, we inserted the IVPA/US catheter, 
partially enclosed with a polyimide sheath, through the hemostatic introducer sheath and advanced it distally to 
a point of resistance (from tortuous anatomy). We completed a pullback of the entire artery length at a pullback 
rate of 0.2 mm/s and 1 fps imaging speed. After we identified a positive region of interest (an area with strong sig-
nal from the IVPA channel), we repeated imaging at 16 fps. We identified and marked the catheter tip location in 
the vessel at our imaged region of interest by using a metal pin that was strongly echogenic on IVUS. This region 
was grossly segmented into a ~2.5 mm section and further sectioned at multiple 250 µm levels and stained with 
Russell-Movat’s pentachrome.
Ethics statement. All the experiment protocols in this study were approved by the Institutional Biosafety 
Committee of Purdue University, and in accordance with the approval guidelines. The experiments involving 
human artery samples were approved by Human Research Protection Program of Purdue University, and the 
informed consent was obtained from all subjects.
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